Archive | Hot Mandates RSS feed for this section

Hot Investor Mandate: USA-Based VC Firm Deploys Up to $10M in Global Devices, Diagnostics, Digital Health Companies Across Various Subsectors and Indications

11 Mar

A venture capital firm founded in 2020 and based in the USA is seeking opportunities in the medical devices, diagnostics, and digital health sectors of life sciences. The firm is looking to engage in Series A to Series B financing rounds with check sizes between 5 – 10 million USD. The firm prefers to lead the financing rounds but is open to co-investing. The firm will consider opportunities globally.

The firm is interested in early-stage opportunities in medical devices, diagnostics, and digital health sectors but does not invest in therapeutics. The firm is overall opportunistic and will consider various subsectors and indications. For digital health, The firm prefers b-to-b over b-to-c products. The firm will invest in all early-stage companies including pre and post commercial enterprises.

The firm seeks to work with management teams that have prior entrepreneurial experience. The firm prefers to lead financing rounds and will most likely take a board seat when leading. The firm considers themselves an active investor and will work closely with companies.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com.

Hot Investor Mandate: VC Firm with Strong USA & Asia Presence Invests in Digital Health & Non-Invasive Devices, Open to All Indications

11 Mar

A venture capital firm founded in 2007 with offices in USA and Asia has deep business expertise across these geographies and works with a close network of over 30 large Asian companies, which enables the firm to help portfolio companies beyond capital investment. The firm focuses on Series A financing round primarily in US startups with initial investment sizes ranging between $3-5M (USD) but will selectively participate in Seed and Series B rounds as well. The firm seeks to make 5-7 investments per year, and will selectively consider investment opportunities globally.

The firm invests in a wide range of technology subsectors, including consumer tech and enterprise solutions. In the life sciences/healthcare space, the firm is most interested in health IT/digital health companies including non-invasive health devices, data informatics and SaaS healthcare solutions. The firm is indication agnostic.

The firm seeks to invest in companies with strong potential in the US and Asia markets that could benefit from the firm’s value add-on. The firm prefers to act as the lead investor and have board representation, but is open to co-investing in select cases.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com.

Hot Mandate: CA Based Newly Established VC Invests In Digital Health Technologies, Including AI-Powered Healthcare Solutions

8 Mar

A newly established venture capital firm founded in 2020 and is based in San Francisco, CA. The firm is expecting to close their first fund this year, targeting $100M, and is seeking to invest in Seed to Series A companies. The firm expects to make about 80% of their investments in North America, but has a global

Within life sciences, the firm is most interested in digital health technologies, including Digital Therapeutics, AI-powered healthcare solutions, smart devices, and tech-enabled services. The firm will be extremely selective about medical device companies without a digital component. The same applies for traditional therapeutics and diagnostics sectors as well. The firm likes to see early traction (i.e. paying customer engagement), but is open to pre-revenue companies.

The firm is open to working with all kinds of management teams. The firm is capable of leading seed rounds and can act as either lead or co-investor.

If you are interested in more information about this investor and other investors tracked by LSN, please email 4dmeetsai@lifesciencenation.com.

Hot Mandate: NY Based Family Office Interested In AI-related Digital Health Technologies

8 Mar

A family office based in New York, NY is looking to invest in medical devices and diagnostics, but will also consider therapeutics and digital health. The firm prefers companies that have some proof of concept data, with some animal studies complete, and will invest through to clinical-stage companies. The firm generally co-invests in a syndicate, and will invest between $100-500K, depending on the stage of development of the company. The firm is currently interested in investing in companies located in North America.

The firm is focused primarily on medical devices and diagnostics, but will consider therapeutics, if they are first in class, and digital health, with a focus on AI-related technologies. The firm has focused on

The firm is interested in companies with strong management teams. As the firm will generally co-invest, board representation is not usually required after investing.

If you are interested in more information about this investor and other investors tracked by LSN, please email 4dmeetsai@lifesciencenation.com.

Hot Mandate: VC Focuses On Early-Stage Personalized Diagnostics With Big Data Component

8 Mar

A recently formed venture capital firm that focuses on the big-data aspect of personalized diagnostics is seeking early-stage companies raising seed to Series B rounds. The firm has a $200M target fund and seeks to make 15 –20 new investments within the year. The firm seeks to make $2M – $4M initial investments per company, but will make smaller initial seed investments. The firm prefers to be actively involved in their portfolio companies, and therefore prefers companies based near the west coast, though is open to other U.S.-based companies.

The firm is focused on early-detection diagnostics, such as discovering cancer when it is still monogenetic versus heterogeneous and already invaded in other parts of the body or detecting Alzheimer’s 8-10 years before dementia symptoms are present. The firm is interested in point-of-care diagnostics (for influenza A/B/bacterial, etc.) that can diagnose specifically and efficiently. The firm is especially interested in technology with a big-data component, and involved in genomics and personalized medicine to provide the right treatment as early as possible. The firm seeks preclinical to clinical-stage technology, though will also look later-stage depending on the opportunity.

The firm requires a smart management team that is diverse in knowledge, and a company with good IP that may come from a leading institution. The firm will usually seek early-stage companies with less than half a dozen people.

If you are interested in more information about this investor and other investors tracked by LSN, please email 4dmeetsai@lifesciencenation.com.

Hot Mandates: California-based Venture Capital

8 Mar

A Venture Capital firm based in San Francisco California. The firm is interested in making equity investments into early-stage companies with investments ranging from $1M to $15 million per company, depending on the companies needs and stage of development. The firm is currently seeking investment opportunities throughout the United States.

The firm is looking for companies operating in the HIT/ Digital Health space as well as diagnostics and devices with a software component. The firm is entirely opportunistic in terms of indication and will consider companies at all stages of development. Specific areas of interest include life science tools, mental health, digital therapeutics, synthetic biology and 3D printing.

The firm is looking for privately held companies with strong management teams. The firm is able to provide entrepreneurs with a 200-person advisory network and bring deep operational expertise.

If you are interested in more information about this investor and other investors tracked by LSN, please email LHI@lifesciencenation.com.

Hot Mandates: Texas-based Family Office

8 Mar

A Dallas, Texas based VC firm that was founded in 2011 and is focused on healthcare companies. The firm makes seed, venture, and growth stage investments. The firm typically provides seed and Series A equity financing in the range of $100K to $1M per portfolio company. The firm generally acts as the lead investor and is open to investing in syndicates. The firm primarily invests in companies that are based in Texas but is open to opportunities across North America. The firm is actively seeking new investment opportunities.

The firm is currently seeking to invest in medical devices, diagnostics, digital health, and software. The firm is also interested in reformulated and repurposed drugs that have mitigated risk. For medical devices, the firm is opportunistic in terms of subsectors. Ideally, the product has a prototype and 510(k) regulatory pathway. The firm is open to investing in any indication, including orphan diseases; the dental field is of interest.

The firm seeks a strong and experienced management team. The firm may take a board seat where appropriate.

If you are interested in more information about this investor and other investors tracked by LSN, please email LHI@lifesciencenation.com.

← Older Entries
Newer Entries →